Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Desogestrel,Ethinyl Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved
Sponsor : Organon
Deal Size : Undisclosed
Deal Type : Acquisition
Details : This acquisition gives Organon full global ownership of Marvelon® and Mercilon® brands (except in South Korea) by reacquiring the rights to them in these markets. Marvelon and Mercilon are currently available by prescription in Vietnam.
Brand Name : Marvelon
Molecule Type : Small molecule
Upfront Cash : Undisclosed
February 16, 2022
Lead Product(s) : Desogestrel,Ethinyl Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved
Sponsor : Organon
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?